why novartis� landmark cancer drug approval is great news for bluebird.
.
..
share on twitter twitter
.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..